A.G.E. Eye Complex

A.G.E. Advanced Eye is a next-generation eye cream that fights the appearance of crow's feet, puffiness, and dark circles associated with glycation and collagen decline, a major factor of the natural aging process. This silky eye cream is formulated for the delicate eye area with a potent combination of ProxylaneTM, a concentrated flavonoid blend, glycyrrhetinic acid, and Matrixyl 3000. This eye cream also includes caffeine and an inclusive blend of optical diffusers to disperse light and immediately improve the radiance of tired, dull-looking eyes across all skin tones.

Key Ingredients:

• 7.15% Concentrated ProxylaneTM: Helps support skin and correct visible signs of aging like wrinkles and laxity.
• 4.25% Wild Fruit Flavonoid Blend: Helps reduce oxidative stress and protect against free radical damage.
• 3% Matrixyl 3000: Powerful biomimetic peptide to support skin's natural firmness and elasticity for a youthful look.
• 0.2% Glycyrrhetinic Acid: Helps counter dull tone, which can be linked to A.G.E. accumulation, and is known for its soothing properties.
• 0.8% Inclusive Optical Effects: Disperses light to minimize the appearance of dark circles and improve the radiance of tired, dull eyes across all skin tones.
• 0.5% Caffeine: Reduces visible puffiness and the look of dark circles for a more vibrant appearance.

Benefits:

• Reduces the appearance of crow's feet
• Improves the look of puffiness and dark circles
• Instantly enhances radiance around the eyes, across all skin tones
• Restores moisture to dry, aging skin
• Paraben-, fragrance-, and dye-free
• TSA approved

Visible Results:

In an 8-week study, A.G.E. Advanced Eye significantly improved the appearance of key visible signs of aging.

IMMEDIATE RESULTS

• Brightens dark circles by 12.4%
• Delivers 24-hour hydration

AFTER 8 WEEKS

• 18.0% improvement in crow's feet
• 23.6% improvement in under-eye wrinkles
• 24.0% improvement in puffiness

Protocol: An 8-week, single-center, double-blind clinical study was conducted on 89 females with Fitzpatrick type I-VI, ages 35-65, and mild to moderate aging signs in the periocular area. A.G.E. Advanced Eye was used twice daily around the eye area in conjunction with a sunscreen. Efficacy and tolerance evaluations were conducted at baseline, post-application, and week 8. Additionally, ultrasound measurements on crow's feet were conducted at baseline and week 8.